268 related articles for article (PubMed ID: 24055305)
1. An adult zebrafish model for preclinical tuberculosis vaccine development.
Oksanen KE; Halfpenny NJ; Sherwood E; Harjula SK; Hammarén MM; Ahava MJ; Pajula ET; Lahtinen MJ; Parikka M; Rämet M
Vaccine; 2013 Oct; 31(45):5202-9. PubMed ID: 24055305
[TBL] [Abstract][Full Text] [Related]
2. DNA vaccination boosts Bacillus Calmette-Guérin protection against mycobacterial infection in zebrafish.
Oksanen KE; Myllymäki H; Ahava MJ; Mäkinen L; Parikka M; Rämet M
Dev Comp Immunol; 2016 Jan; 54(1):89-96. PubMed ID: 26363085
[TBL] [Abstract][Full Text] [Related]
3. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel antigen candidates for a tuberculosis vaccine in the adult zebrafish (Danio rerio).
Myllymäki H; Niskanen M; Oksanen KE; Sherwood E; Ahava M; Parikka M; Rämet M
PLoS One; 2017; 12(7):e0181942. PubMed ID: 28742838
[TBL] [Abstract][Full Text] [Related]
5. [A study of the protective effect of the DNA vaccine encoding tubercle antigen 85B with MPT64 in mice challenged with Mycobacterium tuberculosis].
Luo XD; Zhu DY; Chen Q; Jiang Y; Jiang S; Yang C
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Sep; 27(9):611-6. PubMed ID: 15498274
[TBL] [Abstract][Full Text] [Related]
6. Identification of protective postexposure mycobacterial vaccine antigens using an immunosuppression-based reactivation model in the zebrafish.
Myllymäki H; Niskanen M; Luukinen H; Parikka M; Rämet M
Dis Model Mech; 2018 Mar; 11(3):. PubMed ID: 29590635
[TBL] [Abstract][Full Text] [Related]
7. Differential immunogenicity and protective efficacy of DNA vaccines expressing proteins of Mycobacterium tuberculosis in a mouse model.
Fan X; Gao Q; Fu R
Microbiol Res; 2009; 164(4):374-82. PubMed ID: 17764918
[TBL] [Abstract][Full Text] [Related]
8. Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.
van Dissel JT; Soonawala D; Joosten SA; Prins C; Arend SM; Bang P; Tingskov PN; Lingnau K; Nouta J; Hoff ST; Rosenkrands I; Kromann I; Ottenhoff TH; Doherty TM; Andersen P
Vaccine; 2011 Mar; 29(11):2100-9. PubMed ID: 21256189
[TBL] [Abstract][Full Text] [Related]
9. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice.
Yuan W; Dong N; Zhang L; Liu J; Lin S; Xiang Z; Qiao H; Tong W; Qin C
Vaccine; 2012 Mar; 30(14):2490-7. PubMed ID: 21704108
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effects of Ag85B and MPT64 DNA vaccines in a murine model of Mycobacterium tuberculosis infection.
Zhu D; Jiang S; Luo X
Vaccine; 2005 Aug; 23(37):4619-24. PubMed ID: 16053938
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium tuberculosis defective in phthiocerol dimycocerosate translocation provides greater protective immunity against tuberculosis than the existing bacille Calmette-Guérin vaccine.
Pinto R; Saunders BM; Camacho LR; Britton WJ; Gicquel B; Triccas JA
J Infect Dis; 2004 Jan; 189(1):105-12. PubMed ID: 14702160
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with a Sindbis virus-based DNA vaccine expressing antigen 85B induces protective immunity against Mycobacterium tuberculosis.
Derrick SC; Yang AL; Morris SL
Infect Immun; 2005 Nov; 73(11):7727-35. PubMed ID: 16239577
[TBL] [Abstract][Full Text] [Related]
14. Enhanced protection against tuberculosis by vaccination with recombinant Mycobacterium microti vaccine that induces T cell immunity against region of difference 1 antigens.
Brodin P; Majlessi L; Brosch R; Smith D; Bancroft G; Clark S; Williams A; Leclerc C; Cole ST
J Infect Dis; 2004 Jul; 190(1):115-22. PubMed ID: 15195250
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.
Changhong S; Hai Z; Limei W; Jiaze A; Li X; Tingfen Z; Zhikai X; Yong Z
Tuberculosis (Edinb); 2009 Jan; 89(1):54-61. PubMed ID: 19056317
[TBL] [Abstract][Full Text] [Related]
16. A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.
Geluk A; van den Eeden SJ; van Meijgaarden KE; Dijkman K; Franken KL; Ottenhoff TH
Vaccine; 2012 Dec; 30(52):7513-21. PubMed ID: 23103299
[TBL] [Abstract][Full Text] [Related]
17. Immune and histopathologic responses of DNA-vaccinated hybrid striped bass Morone saxatilis x M. chrysops after acute Mycobacterium marinum infection.
Pasnik DJ; Smith SA
Dis Aquat Organ; 2006 Nov; 73(1):33-41. PubMed ID: 17240750
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B
Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695
[TBL] [Abstract][Full Text] [Related]
19. DNA vaccine encoding ESAT-6 enhances the protective efficacy of BCG against Mycobacterium tuberculosis infection in mice.
Fan X; Gao Q; Fu R
Scand J Immunol; 2007 Nov; 66(5):523-8. PubMed ID: 17916110
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and therapeutic effects of Ag85A/B chimeric DNA vaccine in mice infected with Mycobacterium tuberculosis.
Liang Y; Wu X; Zhang J; Xiao L; Yang Y; Bai X; Yu Q; Li Z; Bi L; Li N; Wu X
FEMS Immunol Med Microbiol; 2012 Dec; 66(3):419-26. PubMed ID: 23163873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
